Advanced Oncology Article Search

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Top Read Oncology Articles

Top Read since last login

1 Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial The Lancet Oncology, April 3, 2015

2 Association between abortion and breast cancer: an updated systematic review and meta-analysis based on prospective studies Cancer Causes and Control, April 7, 2015    Evidence Based Medicine    Review Article

3 Screening and routine supplementation for iron deficiency anemia: a systematic review Pediatrics, April 1, 2015    Review Article

4 Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): A randomised, open-label, multicentre, phase 3 trial The Lancet Oncology, March 25, 2015

5 Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: A correlative biomarker study The Lancet Oncology, April 2, 2015

6 Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial The Lancet, April 14, 2015    Evidence Based Medicine

7 Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy Breast Cancer Research and Treatment, April 24, 2015

8 Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: A meta-analysis Cancer Causes and Control, April 6, 2015    Evidence Based Medicine

9 Rituximab after autologous stem cell transplantation enhances survival of b-cell lymphoma patients: a meta-analysis and systematic review Transplantation Proceedings, March 30, 2015    Evidence Based Medicine    Review Article

10 Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo International Journal of Urology, April 3, 2015


New! Conference Interviews

Video Interview

Conference reports and videos; experts discuss new research! See the Latest Highlights